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Abstract A potato virus X (PVX) vector was used to express a
single chain antibody fragment (scFv) against the herbicide
diuron, as a fusion to the viral coat protein. The modified virus
accumulated in inoculated Nicotiana clevelandii plants and
assembled to give virus particles carrying the antibody fragment.
Electron microscopy was used to show that virus particles from
infected leaf sap were specifically trapped on grids coated with a
diuron-BSA conjugate. The results demonstrate that the PVX
vector can be used as a presentation system for functional scFv.
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1. Introduction
Plant virus vectors are being used increasingly for the ex-
pression of foreign genes in plants, and a number of di¡erent
viruses have been successfully developed into tools for gene
delivery [1]. Due to the high level of accumulation of plant
viruses, and the correspondingly high levels of viral gene ex-
pression, much interest has focused on developing virus vec-
tors for the production of valuable proteins in plants. Several
gene insertion vectors have been developed to allow the pro-
duction of foreign proteins, either free in the plant cytoplasm,
or targeted to cellular compartments [2^5].
An alternative to free protein production is to express for-
eign peptides and proteins as fusions to the viral coat protein,
which, following virus assembly, can display the foreign se-
quence at the surface of the assembled particle. Research in
this area has focused on the development of plant viruses
carrying antigenic epitopes from human or animal pathogens
with the aim of developing novel recombinant vaccines. Cow-
pea mosaic virus (CPMV) forms icosahedral particles, and is
one of the best-studied systems for peptide presentation on the
surface of a plant virus [6]. The development of CPMV as a
peptide presentation system mirrored previous studies using
the structurally related poliovirus [7]. CPMV has been used to
present a number of di¡erent antigenic peptides on the par-
ticle surface [8,9]. Similar antigen presentation systems have
been described for the icosahedral tomato bushy stunt virus
[10], the bacilliform alfalfa mosaic virus (AlMV) [11], and the
rod-shaped tobacco mosaic virus (TMV) [12^14]. The value of
this approach is demonstrated by recent reports of protective
immunity against rabies and foot-and-mouth disease virus
(FMDV), conferred respectively by recombinant AlMV and
CPMV particles carrying antigenic epitopes from the corre-
sponding pathogen [15,16]. However, despite successes in pre-
sentation of antigenic peptides on the surface of TMV, CPMV
and AlMV particles, the size of peptide fusions that still per-
mit virus assembly is limited. Only peptides of less than 22
amino acids have been described for TMV-coat protein (CP)
fusions, whereas for recombinant CPMV and AlMV particles,
fusions have been limited to 30 and 47 amino acids, respec-
tively [11,17].
We previously described a potato virus X (PVX)-based vec-
tor that allowed the production of virus particles decorated at
their outer surface with the 27 kDa (237 amino acid) green
£uorescent protein (GFP) as a fusion to the viral CP [18].
Although the GFP-CP fusion protein was unable on its own
to assemble into virus, it was found that assembly of particles
occurred when free CP was present in addition to the GFP-CP
fusion. The requirement for free CP, in addition to the fusion
protein, presumably re£ects steric constraints on particle as-
sembly imposed by the addition of foreign sequence. To pro-
vide both GFP-CP fusion protein and free CP, a strategy was
developed that used the 16 amino acid 2A peptide from
FMDV, positioned as a translational fusion between the ami-
no-terminal GFP and the carboxy-terminal CP domains. The
2A peptide, which mediates a co-translational processing
event in the maturation of the FMDV polyprotein, is also
able to process synthetic polypeptides [19,20]. In plants in-
fected by the modi¢ed PVX, accumulation of cleaved CP
and GFP-2A along with uncleaved GFP-2A-CP fusion pro-
tein was observed. The GFP-2A-CP fusion protein subunits,
in combination with free CP subunits, could assemble into
¢lamentous rod-shaped particles that were decorated at their
outer radius with GFP. Furthermore, the modi¢ed virus re-
tained the ability to move locally and systemically through the
plant [18].
The utility of a GFP-tagged virus in studying viral patho-
genesis is well established [18,21]; however, the possibility of
tagging other proteins to PVX particles provides the oppor-
tunity for a wide range of biotechnological applications. In
order to demonstrate the production of a functional recombi-
nant protein attached to PVX CP we investigated the expres-
sion and presentation of a single chain antobody fragment
(scFv) against the herbicide diuron in plants.
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2. Materials and methods
2.1. Plasmid construction
Standard DNA manipulation techniques were used throughout [22].
Plasmid L41 (L. Smolenska and S. Santa Cruz, unpublished) is based
on pTXS.GFP-CP [18] but replaces the sequence encoding the two N-
terminal amino acids of the FMDV 2A linker peptide with the rec-
ognition sequences for the restriction enzymes BspEI and XbaI. L41
was digested with EagI and BspEI to delete the GFP coding sequence.
The plasmid pSDLG2-FLAG, which encodes the anti-diuron scFv
fragment [23], was used as template for PCR ampli¢cation with oli-
gonucleotide primers designed to introduce recognition sequences for
EagI and BspEI at the 5P and 3P ends, respectively, of the ampli¢ed
DNA. Following digestion with EagI and BspEI the PCR product
encoding the scFv was ligated to L41, replacing the deleted GFP
sequence. The resulting plasmid, pTXS.KD-CP, encodes a translation-
al fusion between the scFv, the 2A peptide and the CP. pTXS.KD-CP
was digested with the restriction enzymes ClaI and EagI to allow the
insertion of an epitope tag at the amino-terminus of the polyprotein
coding sequence. Two complementary oligonucleotides, encoding the
eight amino acid FLAG tag, were annealed and ligated to pTXS.KD-
CP to give pTXS.FKD-CP.
2.2. In vitro transcription and plant inoculation
In vitro run-o¡ transcripts were synthesised from SpeI-digested
pTXS.FKD-CP using a T7 RNA polymerase transcription kit (Am-
bion, Austin, TX, USA). Transcripts were inoculated directly to
young leaves of Nicotiana clevelandii plants by rubbing aluminium
oxide-dusted leaves. Each leaf was inoculated with transcript products
derived from 0.4 Wg of plasmid template.
2.3. Immunoblot analysis
Protein extracts from inoculated leaf tissue, harvested 5 days post
inoculation (dpi), were prepared for SDS-polyacrylamide gel electro-
phoresis and blotting to nitrocellulose as described previously [18].
The M5 monoclonal antibody raised against the FLAG epitope (Sig-
ma, St Louis, MO, USA) and rabbit polyclonal antiserum raised
against PVX coat protein were used for immunodetection.
2.4. Immunosorbent electron microscopy
Electron microscope grids with a carbon support ¢lm were coated
with diuron-BSA conjugate at a concentration of 0.01 Wg/ml and
control grids were coated with BSA alone at the same concentration.
Coated grids were incubated on drops of sap from virus-infected leaf
tissue, and then negatively stained with 2% sodium phosphotungstate
(pH7) before observation using a JEOL 1200 electron microscope
(JEOL, London, UK). All immunosorbent electron microscopy meth-
ods used have been described previously [24]. Diuron-BSA conjugate
was prepared using a standard protocol for the conjugation of car-
boxylic acid haptens to proteins [25].
3. Results and discussion
3.1. Plant inoculation and protein analysis
In vitro run-o¡ transcripts synthesised from pTXS.FKD-CP
(Fig. 1) were infectious when inoculated to plants. Virus de-
rived from transcript inoculation is subsequently referred to as
PVX.FKD-CP. Symptoms of viral infection were observed by
5 dpi on inoculated leaves, and by 8 dpi on non-inoculated
leaves (data not shown). Western blot analysis of protein ex-
tracts from inoculated N. clevelandii leaves, harvested at 4 dpi,
demonstrated the presence of both CP and FLAG antigen.
Immunoblots probed with antiserum raised against the CP
(Fig. 2A) show two immunoreactive bands, corresponding
to the scFv-2A-CP fusion protein and the cleaved CP. Sim-
ilarly, blots probed with antiserum raised against the FLAG
epitope also show two bands, corresponding to the unpro-
cessed fusion protein and to cleaved scFv-2A (Fig. 2B).
Thus, translation of the synthetic scFv-2A-CP polyprotein
results in the accumulation of both unprocessed polyprotein
and the products of 2A-mediated processing, scFv-2A and
CP.
Based on analysis of immunoblots probed with antibody
raised against the CP, and comparison with puri¢ed CP
standards, we estimate that in PVX.FKD-CP infected leaf tis-
sue, CP accumulated to approximately 200^500 Wg/g fresh
weight tissue by 4 dpi (data not shown). In the absence of a
standard we were unable to quantify directly the level of scFv
produced, however, CP and scFv are produced at exactly the
same level, and approximately 50% of detected scFv antigen is
present as fusion to CP (Fig. 2). We therefore estimate the
level of scFv-2A-CP fusion protein as approximately 100^250
Wg/g fresh weight tissue by 4 dpi.
3.2. Immunotrapping of virus particles
To establish whether virus particles were assembled that
contained the scFv-2A-CP polyprotein, and whether the
scFv domain remained functional for antigen binding, sap
from PVX.FKD-CP-infected leaves was incubated with car-
bon support ¢lm grids carrying either a diuron-BSA conjugate
or BSA alone. The results of this immunosorbent antigen
binding assay (Table 1) show a 60-fold increase in virus par-
ticles trapped on diuron-BSA-coated ¢lms compared with
BSA-coated control ¢lms. In contrast, similar numbers of
particles were trapped on both diuron-BSA and BSA ¢lms
incubated with sap prepared from leaf tissue infected with
wild-type PVX, con¢rming that the trapping of PVX.FKD-
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Fig. 1. Organisation of the wild-type PVX and PVX.FKD-CP ge-
nomes. Schematic representation (not to scale) of the wild-type
PVX and recombinant PVX.FKD-CP viral genomes. Lines represent
untranslated sequence and boxes represent coding sequences. The
size of virus-coded proteins is shown (kDa); CP, coat protein; F,
FLAG tag; scFv, single chain antibody.
Table 1
Immunotrapping of virus particles on coated carbon support ¢lm electron microscopy grids
Inoculum Grid coating Virus particles/1000 Wm2 Factorial increasea
PVX.FKD-CP diuron-BSA 1490 62.1
BSA 24 ^
Wild-type PVX diuron-BSA 111 1.3
BSA 85 ^
aRelative increase in particle trapping on diuron-BSA-coated grids compared to grids coated with BSA alone.
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CP particles on diuron-BSA-coated grids was due to incorpo-
ration of the scFv-2A-CP polyprotein into virus particles. This
speci¢c trapping of PVX.FKD-CP virus particles, on grids
coated with the diuron-BSA conjugate, provides clear evi-
dence that functional scFv could be incorporated into virus
particles as a fusion to the viral CP. The PVX.FKD-CP par-
ticles trapped on diuron-BSA-coated grids appeared as ¢la-
mentous rods typical of wild-type PVX particles (Fig. 3).
The antigen binding properties of antibodies are exploited
in many biological, biotechnological and medical applications
and plants are increasingly being used as expression systems
for antibody production [26]. Expression of both complete
[27,28] and engineered antibodies [29,30] in transgenic plants
is well documented. Furthermore, the functionality of trans-
genically expressed antibodies has been demonstrated both in
situ [29,30] and ex situ [31]. However, all plant-based antibody
expression systems described so far have relied on the prepa-
ration of transgenic plant lines. Here we describe an alterna-
tive system for rapidly producing functional scFv in plants.
These data extend previous results and demonstrate that the
PVX vector can be used for the presentation of functional
scFv antibody fragments in plants. In the case of the scFv
used in this study, which recognises the herbicide diuron, po-
tential in situ applications include remediation of contami-
nated soils and waterways. The practical bene¢ts of using
plants as cheap, self-maintaining, bioreactors for the produc-
tion of antibodies has been exempli¢ed recently by the dem-
onstration of e¡ective preventative immunotherapy using a
secretory antibody produced in transgenic plants [31]. The
development of viruses as expression tools for the production
of functional scFv will extend the utility of plant-based anti-
body production and provides a novel means for directing
high-level expression of a carrier-linked scFv in plants.
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